WHO ICTRP trial
The impact of paclitaxel combined with platinum - based neoadjuvant chemotherapy…
ChiCTR2500102477 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500102477 |
|---|---|
| Public title | The impact of paclitaxel combined with platinum - based neoadjuvant chemotherapy on the vascular reactivity of the radial and ulnar arteries following radial artery catheterization |
| Scientific title | The impact of paclitaxel combined with platinum - based neoadjuvant chemotherapy on the vascular reactivity of the radial and ulnar arteries following radial artery catheterization |
| Primary sponsor | Jiangsu Province Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Cervical cancer, ovarian cancer, endometrial cancer. |
| Interventions | Chemotherapy Group :None;Non-Chemotherapy Group:None |
| Registration date | May 15, 2025 |
| Target size | Chemotherapy Group :43;Non-Chemotherapy Group:43 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: